Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
3,701
NCT02491229
"Hepafast in Non-alcoholic Fatty Liver Disease (NAFLD)"
Phase: N/A
Role: Collaborator
Start: Jan 31, 2015
Completion: Dec 31, 2015
NCT05017493
Treatment of Covid-19 With a Herbal Compound, Xagrotin
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 1, 2020
Completion: Feb 8, 2021
NCT05222425
Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
Phase: Phase 3
Start: Jun 1, 2022
Completion: Dec 7, 2022